A practical reference on DMSO stock: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2025-12-24. Anything still debated is marked as such rather than presented as settled.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ, also called NR1D1 and NR1D2. These receptors help regulate circadian rhythms and metabolic gene programs. The compound was developed for laboratory research, not as an approved therapeutic. Its identity is distinct from steroid hormones and selective androgen receptor modulators. Scientific interest centers on how REV-ERB activation changes gene expression in cells and animal models.
At the molecular level, SR9009 binds the ligand-binding domain of REV-ERB and strengthens recruitment of corepressor proteins such as NCoR and HDAC3. This increases repression of target genes, including Bmal1 and other clock-controlled and metabolic genes. In rodent studies, such changes have been linked to altered lipid handling, glucose metabolism, and energy expenditure. The precise chain of events between receptor binding and whole-body effects remains an active area of research. Findings in animals do not automatically translate to humans.
Analytical methods for SR9009 typically rely on liquid chromatography coupled with tandem mass spectrometry. The technique can separate the parent compound from related substances and detect low concentrations in biological matrices. Urine and blood are common samples in anti-doping testing, while in vitro studies may use cell culture media. Rapid metabolism and low expected concentrations make method validation important for reliable identification. Exact metabolite patterns can vary by species and are not fully mapped.
Regulatory treatment of SR9009 reflects its investigational status. The compound has no approved human therapeutic indication, and sports authorities prohibit its use. It appears on anti-doping lists as a non-approved substance or metabolic modulator, depending on the list version. Products sold online as research chemicals are not quality-controlled medicines, so their identity and purity can differ from the label. Such products may also contain unlisted compounds, which complicates both testing and safety assessment.
Scientific discussion of SR9009 often separates animal evidence from human anecdote. Rodent studies provide controlled data on endurance, metabolism, and gene expression, but they use specific strains, doses, and treatment durations. Human reports are mostly uncontrolled and cannot establish cause and effect. Open questions include oral bioavailability, tissue distribution, metabolic stability, and long-term effects. Review articles generally call for more rigorous pharmacokinetic and safety research before any clinical use could be considered.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic small molecule | Studied as a REV-ERB agonist |
| Molecular formula | C20H24ClN3O4S | Reported for the neutral compound |
| Appearance | Off-white to pale yellow solid | Typical research-grade material |
| Solubility | Sparingly soluble in water | Soluble in solvents such as DMSO |
| Common synonyms | SR9009; Stenabolic | Stenabolic is an informal alias |
Preclinical reports have linked SR9009 to improved endurance and altered energy expenditure in rodents. Such findings have prompted interest in whether REV-ERB activation can influence skeletal muscle metabolism. However, the reported effects depend on dose, route, and experimental model, and replication across laboratories is limited. Human trials have not established comparable outcomes, so claims about exercise performance remain speculative. The absence of controlled human data is a central limitation in interpreting these observations.
The mechanism of action involves binding to REV-ERB receptors and recruiting corepressor complexes, which represses target gene transcription. This contrasts with many nuclear receptor agonists that activate transcription. Downstream effects may include changes in autophagy, mitochondrial biogenesis, and lipid handling, but the precise pathways remain an active area of study. Whether these molecular events translate into meaningful physiological effects in humans is unresolved. Most evidence comes from cultured cells and rodent models rather than human participants.
Laboratory samples of SR9009 are typically handled as research chemicals rather than pharmaceuticals. Suppliers usually state that the material is for research use only and not for human or veterinary administration. Storage recommendations generally call for a freezer at approximately −20 °C, protection from light, and a desiccated environment. The solid is often described as a white to off-white powder. Solubility is commonly reported in organic solvents such as dimethyl sulfoxide and ethanol, with low solubility in water.
Analytical identification and purity assessment often use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Liquid chromatography–tandem mass spectrometry is used to detect and quantify SR9009 in biological matrices, including urine and blood, for anti-doping or pharmacokinetic studies. Nuclear magnetic resonance spectroscopy can confirm molecular structure. Stability depends on form and storage: the solid is generally more stable than solutions, and repeated freeze–thaw cycles may degrade samples. Purity is typically reported as a percentage from a certificate of analysis.
Regulatory treatment of SR9009 varies by country and context. It is not approved as a therapeutic drug by agencies such as the United States Food and Drug Administration or the European Medicines Agency. Sports authorities list it as a prohibited substance; the World Anti-Doping Agency classifies it among hormone and metabolic modulators. Legal status for personal possession or sale differs across jurisdictions, and some countries may restrict it under analog or research chemical laws. Buyers who seek verified material often rely on independent laboratory testing because online product labels may not match contents.
Laboratory identification of SR9009 typically relies on chromatographic separation coupled to mass spectrometry, often with ultraviolet detection as a secondary check. Nuclear magnetic resonance spectroscopy can confirm molecular structure when a reference standard is available. Because many suppliers sell the compound as a research chemical, independent identity testing is important for experimental reproducibility. A single retention time is not sufficient proof of identity, especially when related compounds may be present. Purity assessments usually report a percentage based on area normalization.
SR9009 is generally described as poorly soluble in water and more soluble in organic solvents such as dimethyl sulfoxide and ethanol. Stock solutions are commonly prepared in an organic solvent before dilution into an aqueous buffer or vehicle. Precipitation can occur if the organic fraction is reduced too quickly or if the final concentration exceeds the compound's solubility limit. Sonication or gentle warming may aid dissolution in some protocols, but excessive heat can promote degradation. Container material and pH can also influence observed solubility.
For long-term storage, SR9009 is typically kept as a solid at low temperature, protected from moisture and light. Desiccated conditions limit hydrolysis, while opaque containers reduce photochemical breakdown. Solutions are less stable than solids and are often stored frozen in aliquots to avoid repeated freeze-thaw cycles. Stability data are not standardized across all suppliers, so users should rely on certificate-of-analysis information when available. Degradation may appear as color change, precipitate, or decreased chromatographic purity.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not an approved medicine and has no established human therapeutic use. The compound appears in scientific literature as a tool for probing circadian and metabolic regulation. Online sellers often label it as a research chemical, sometimes using the nickname Stenabolic. Its chemical identity is distinct from selective androgen receptor modulators, stimulants, and peroxisome proliferator-activated receptor delta agonists. Researchers use it mainly in cell and animal experiments.
At the molecular level, SR9009 binds REV-ERBα and REV-ERBβ and alters their repressive activity on target genes. These nuclear receptors help regulate the circadian clock, lipid synthesis, glucose metabolism, and inflammatory pathways. By changing transcription, the compound can shift the timing or magnitude of downstream metabolic processes in model systems. It does not act through androgen receptors or adenosine receptors, which distinguishes it from several substances sold for athletic performance. Whether the same transcriptional changes occur in humans at tolerable exposures remains an open question because controlled human studies are lacking.
== Diagnosis == Definitive diagnosis is usually made at a reference laboratory with advanced biocontainment capabilities. The findings of laboratory investigation vary somewhat between the viruses but in general, there is a decrease in the total white cell count (particularly the lymphocytes), a decrease in the platelet count, an increase in the blood serum liver enzymes, and reduced blood clotting ability measured as an increase in both the prothrombin (PT) and activated partial thromboplastin times (PTT). The hematocrit may be elevated. The serum urea and creatine may be raised but this is dependent on the hydration status of the patient. The bleeding time tends to be prolonged. Labs can use RT-PCR to detect the genetic material of the virus, or an ELISA test in later stages to detect antibodies produced by the immune system.
The National Socialists supplanted the Social Democrats as the largest party in the Reichstag. As Communists and National Socialists together had won the majority of seats, no government coalition could be formed without one of them. Papen tried to justify his authoritarian style of government by pointing out that parliament could no longer function properly. Countering this reasoning, the Centre and the BVP tried to re-establish a working parliament by cooperation with the National Socialists, since the three parties together had attained 53% of the seats. When Papen called upon the people to "reject the dictatorship of a single party", the Centre Party agreed "without reservation", but it also stated that "with the same resolution we reject the dictatorship of the nameless party, now in power … even if cloaked with the illusion of non-partisanship". After Papen failed to get Hitler's support for his administration, the Centre began their own negotiations with the National Socialists. They started in the state of Prussia, where the Weimar Coalition had just lost its majority. An alternative majority could not be found and the Papen administration had seized this opportunity to assume control of Germany's largest state in the "Prussian coup" via presidential decree. Now, the National Socialists proposed to end this direct rule by forming a coalition with the Centre Party, promising an equal share in government.
==== Carbon-sulfur ==== Prenylcysteine lyase (PCLase) catalyzes the cleavage of prenylcysteine (a protein modification) to form an isoprenoid aldehyde and the freed cysteine residue on the protein target. The FAD is non-covalently bound to PCLase. Not many mechanistic studies have been done looking at the reactions of the flavin, but the proposed mechanism is shown below. A hydride transfer from the C1 of the prenyl moiety to FAD is proposed, resulting in the reduction of the flavin to FADH2. COformED IS a carbocation that is stabilized by the neighboring sulfur atom. FADH2 then reacts with molecular oxygen to restore the oxidized enzyme.
Sources: en.wikipedia.org
== Challenges and limitations == Preserved collections do not encompass all fungal diversity, and many fungal species may never be documented by preserved specimens, particularly when they remain embedded in substrates or do not produce identifiable structures for collection. As a comparatively "hidden" group, fungi are more difficult to collect than plants or animals; whereas herbarium specimens often preserve both vegetative and reproductive parts, fungaria are usually limited to reproductive sporocarps. A significant proportion of fungal biodiversity, estimated at 1.5 to 6 million species, remains unnamed and undocumented. The scientific usefulness of fungarium data can be limited by taxonomic and geographic sampling biases, including strong overrepresentation of some fungal groups and biases linked to human population density and collecting patterns. At global scale, preserved-specimen data remain concentrated in Europe, North America, and Australia and are strongly skewed toward Ascomycota, owing to persistent geographic and taxonomic biases in collecting effort. Interpretation of historical collection data can also be complicated by collecting bias, since specimens were not gathered randomly and many regions remain underrepresented. Large fractions of fungarium holdings may remain unidentified or bear outdated identifications, creating barriers to using collections effectively at scale. The main technical challenge for molecular work is the degradation of DNA over time through deamination and fragmentation.
=== Relationships and family === In December 2001, Newsom married legal commentator Kimberly Guilfoyle at Saint Ignatius Catholic Church. They separated in 2004 and jointly filed for divorce in January 2005, citing "difficulties due to their careers on opposite coasts". Their divorce was finalized on February 28, 2006, by which time Guilfoyle was expecting a child with Eric Villency. Guilfoyle gained prominence in 2011 via a Fox News chat show. She was later named senior advisor to Republican president Donald Trump, whom Newsom has extensively criticized, and was later engaged to Donald Trump Jr. In September 2006, Newsom, then 38, briefly dated 19-year-old Brittanie Mountz, a model and restaurant hostess. On January 31, 2007, Newsom's close friend, campaign manager, and former chief of staff Alex Tourk confronted him after learning from his wife, Ruby Rippey-Tourk, that she and Newsom had an affair in 2005, when she was Newsom's appointments secretary. Tourk immediately resigned. Newsom admitted to the affair the next day and apologized to the public, saying he was "deeply sorry" for his "personal lapse of judgment". In 2018, Rippey-Tourk said that she thought it wrong to associate Newsom's behavior with the #MeToo movement: "I was a subordinate, but I was also a free-thinking, 33-yr old adult married woman and mother. I do want to make sure that the #metoo movement is reserved for cases and situations that deserve it." Newsom began dating film director Jennifer Siebel in October 2006. He announced he would seek treatment for alcohol use disorder in February 2007.
In her autobiography, Out of the Shadows, Anne Marie reflects on how when she asked why her mother had collected Charmaine — who was part-Pakistani, while Anne Marie was fully white — but not her, Fred callously replied: "She wouldn't want you, love. You're the wrong colour." Charmaine's body was initially stowed in the coal cellar of Midland Road until Fred was released from prison. He later buried her naked body in the yard close to the back door of the flat, and remained adamant that he had not dismembered her. A subsequent post-mortem suggested the body had been severed at the hip, but that this damage may have been caused by building work Fred conducted at the property in 1976. Several bones—particularly patellae, finger, wrist, toe and ankle bones—were missing from Charmaine's skeleton, leading to speculation that the missing parts had been retained as keepsakes. This trait would prove to be a distinctive finding in all the autopsies of the Wests' victims when they were exhumed in 1994.
=== Frequently consumed insect species === Human consumption of 2,205 different insect species has been documented. The table below ranks insect order by number and percentage of confirmed species consumed and presents each insect orders' percentage of known insect species diversity. With the exceptions of orders Orthoptera and Diptera, there is close alignment between species diversity and consumption, suggesting that humans tend to eat those insects that are most available.
Sources: en.wikipedia.org
SR9009 is a synthetic research compound that activates the REV-ERBα and REV-ERBβ nuclear receptors. It is not an approved drug and has no established human therapeutic use. Most published biological data come from cell and rodent studies.
No. SR9009 is frequently mislabeled as a SARM in online discussions, but it does not target androgen receptors. Its known mechanism involves REV-ERB nuclear receptors and circadian-metabolic gene regulation.
Human clinical data are very limited. There is no approved human use, and safety and efficacy in people are not established. Most evidence comes from preclinical models, so effects observed in animals may not apply to humans.
No. It is an investigational compound without approved therapeutic indications. It is sold for research purposes only in many jurisdictions.